Global GLP-1-based Therapy Market Growth 2026-2032
The global GLP-1-based Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
GLP-1-based therapy involves the use of medications that mimic the actions of glucagon-like peptide-1(GLP-1).They work by stimulating insulin secretion in response to elevated blood sugar levels,inhibiting glucagon release,delaying gastric emptying,and promoting a feeling of fullness.These effects help to lower blood glucose levels,improve glycemic control,and often result in weight loss,which are primarily used to manage type 2 diabetes mellitus and loss weight.
United States market for GLP-1-based Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for GLP-1-based Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for GLP-1-based Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key GLP-1-based Therapy players cover Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, GSK, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?GLP-1-based Therapy Industry Forecast? looks at past sales and reviews total world GLP-1-based Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected GLP-1-based Therapy sales for 2026 through 2032. With GLP-1-based Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1-based Therapy industry.
This Insight Report provides a comprehensive analysis of the global GLP-1-based Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1-based Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global GLP-1-based Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1-based Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1-based Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1-based Therapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
GLP-1-based therapy involves the use of medications that mimic the actions of glucagon-like peptide-1(GLP-1).They work by stimulating insulin secretion in response to elevated blood sugar levels,inhibiting glucagon release,delaying gastric emptying,and promoting a feeling of fullness.These effects help to lower blood glucose levels,improve glycemic control,and often result in weight loss,which are primarily used to manage type 2 diabetes mellitus and loss weight.
United States market for GLP-1-based Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for GLP-1-based Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for GLP-1-based Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key GLP-1-based Therapy players cover Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, GSK, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?GLP-1-based Therapy Industry Forecast? looks at past sales and reviews total world GLP-1-based Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected GLP-1-based Therapy sales for 2026 through 2032. With GLP-1-based Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1-based Therapy industry.
This Insight Report provides a comprehensive analysis of the global GLP-1-based Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1-based Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global GLP-1-based Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1-based Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1-based Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1-based Therapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injection
- Tablets
- Other
- Type 2 Diabetes
- Obesity
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- Eli Lilly
- AstraZeneca
- Sanofi
- GSK
- Hanson
- Shanghai Renhui Biopharmaceutical
- Huadong Medicine
- Sino Biopharm
- What is the 10-year outlook for the global GLP-1-based Therapy market?
- What factors are driving GLP-1-based Therapy market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doGLP-1-based Therapy market opportunities vary by end market size?
- How does GLP-1-based Therapy break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1-based Therapy Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for GLP-1-based Therapy by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for GLP-1-based Therapy by Country/Region, 2021, 2025 & 2032
2.2 GLP-1-based Therapy Segment by Type
2.2.1 Injection
2.2.2 Tablets
2.2.3 Other
2.2.4 GLP-1-based Therapy Sales by Type
2.2.4.1 Global GLP-1-based Therapy Sales Market Share by Type (2021-2026)
2.2.4.2 Global GLP-1-based Therapy Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global GLP-1-based Therapy Sale Price by Type (2021-2026)
2.3 GLP-1-based Therapy Segment by Application
2.3.1 Type 2 Diabetes
2.3.2 Obesity
2.3.3 GLP-1-based Therapy Sales by Application
2.3.3.1 Global GLP-1-based Therapy Sale Market Share by Application (2021-2026)
2.3.3.2 Global GLP-1-based Therapy Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global GLP-1-based Therapy Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global GLP-1-based Therapy Breakdown Data by Company
3.1.1 Global GLP-1-based Therapy Annual Sales by Company (2021-2026)
3.1.2 Global GLP-1-based Therapy Sales Market Share by Company (2021-2026)
3.2 Global GLP-1-based Therapy Annual Revenue by Company (2021-2026)
3.2.1 Global GLP-1-based Therapy Revenue by Company (2021-2026)
3.2.2 Global GLP-1-based Therapy Revenue Market Share by Company (2021-2026)
3.3 Global GLP-1-based Therapy Sale Price by Company
3.4 Key Manufacturers GLP-1-based Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1-based Therapy Product Location Distribution
3.4.2 Players GLP-1-based Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1-BASED THERAPY BY GEOGRAPHIC REGION
4.1 World Historic GLP-1-based Therapy Market Size by Geographic Region (2021-2026)
4.1.1 Global GLP-1-based Therapy Annual Sales by Geographic Region (2021-2026)
4.1.2 Global GLP-1-based Therapy Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GLP-1-based Therapy Market Size by Country/Region (2021-2026)
4.2.1 Global GLP-1-based Therapy Annual Sales by Country/Region (2021-2026)
4.2.2 Global GLP-1-based Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas GLP-1-based Therapy Sales Growth
4.4 APAC GLP-1-based Therapy Sales Growth
4.5 Europe GLP-1-based Therapy Sales Growth
4.6 Middle East & Africa GLP-1-based Therapy Sales Growth
5 AMERICAS
5.1 Americas GLP-1-based Therapy Sales by Country
5.1.1 Americas GLP-1-based Therapy Sales by Country (2021-2026)
5.1.2 Americas GLP-1-based Therapy Revenue by Country (2021-2026)
5.2 Americas GLP-1-based Therapy Sales by Type (2021-2026)
5.3 Americas GLP-1-based Therapy Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1-based Therapy Sales by Region
6.1.1 APAC GLP-1-based Therapy Sales by Region (2021-2026)
6.1.2 APAC GLP-1-based Therapy Revenue by Region (2021-2026)
6.2 APAC GLP-1-based Therapy Sales by Type (2021-2026)
6.3 APAC GLP-1-based Therapy Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1-based Therapy by Country
7.1.1 Europe GLP-1-based Therapy Sales by Country (2021-2026)
7.1.2 Europe GLP-1-based Therapy Revenue by Country (2021-2026)
7.2 Europe GLP-1-based Therapy Sales by Type (2021-2026)
7.3 Europe GLP-1-based Therapy Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1-based Therapy by Country
8.1.1 Middle East & Africa GLP-1-based Therapy Sales by Country (2021-2026)
8.1.2 Middle East & Africa GLP-1-based Therapy Revenue by Country (2021-2026)
8.2 Middle East & Africa GLP-1-based Therapy Sales by Type (2021-2026)
8.3 Middle East & Africa GLP-1-based Therapy Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1-based Therapy
10.3 Manufacturing Process Analysis of GLP-1-based Therapy
10.4 Industry Chain Structure of GLP-1-based Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1-based Therapy Distributors
11.3 GLP-1-based Therapy Customer
12 WORLD FORECAST REVIEW FOR GLP-1-BASED THERAPY BY GEOGRAPHIC REGION
12.1 Global GLP-1-based Therapy Market Size Forecast by Region
12.1.1 Global GLP-1-based Therapy Forecast by Region (2027-2032)
12.1.2 Global GLP-1-based Therapy Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GLP-1-based Therapy Forecast by Type (2027-2032)
12.7 Global GLP-1-based Therapy Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1-based Therapy Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly GLP-1-based Therapy Product Portfolios and Specifications
13.2.3 Eli Lilly GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca GLP-1-based Therapy Product Portfolios and Specifications
13.3.3 AstraZeneca GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi GLP-1-based Therapy Product Portfolios and Specifications
13.4.3 Sanofi GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 GSK
13.5.1 GSK Company Information
13.5.2 GSK GLP-1-based Therapy Product Portfolios and Specifications
13.5.3 GSK GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 GSK Main Business Overview
13.5.5 GSK Latest Developments
13.6 Hanson
13.6.1 Hanson Company Information
13.6.2 Hanson GLP-1-based Therapy Product Portfolios and Specifications
13.6.3 Hanson GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hanson Main Business Overview
13.6.5 Hanson Latest Developments
13.7 Shanghai Renhui Biopharmaceutical
13.7.1 Shanghai Renhui Biopharmaceutical Company Information
13.7.2 Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Product Portfolios and Specifications
13.7.3 Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shanghai Renhui Biopharmaceutical Main Business Overview
13.7.5 Shanghai Renhui Biopharmaceutical Latest Developments
13.8 Huadong Medicine
13.8.1 Huadong Medicine Company Information
13.8.2 Huadong Medicine GLP-1-based Therapy Product Portfolios and Specifications
13.8.3 Huadong Medicine GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Huadong Medicine Main Business Overview
13.8.5 Huadong Medicine Latest Developments
13.9 Sino Biopharm
13.9.1 Sino Biopharm Company Information
13.9.2 Sino Biopharm GLP-1-based Therapy Product Portfolios and Specifications
13.9.3 Sino Biopharm GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sino Biopharm Main Business Overview
13.9.5 Sino Biopharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1-based Therapy Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for GLP-1-based Therapy by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for GLP-1-based Therapy by Country/Region, 2021, 2025 & 2032
2.2 GLP-1-based Therapy Segment by Type
2.2.1 Injection
2.2.2 Tablets
2.2.3 Other
2.2.4 GLP-1-based Therapy Sales by Type
2.2.4.1 Global GLP-1-based Therapy Sales Market Share by Type (2021-2026)
2.2.4.2 Global GLP-1-based Therapy Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global GLP-1-based Therapy Sale Price by Type (2021-2026)
2.3 GLP-1-based Therapy Segment by Application
2.3.1 Type 2 Diabetes
2.3.2 Obesity
2.3.3 GLP-1-based Therapy Sales by Application
2.3.3.1 Global GLP-1-based Therapy Sale Market Share by Application (2021-2026)
2.3.3.2 Global GLP-1-based Therapy Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global GLP-1-based Therapy Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global GLP-1-based Therapy Breakdown Data by Company
3.1.1 Global GLP-1-based Therapy Annual Sales by Company (2021-2026)
3.1.2 Global GLP-1-based Therapy Sales Market Share by Company (2021-2026)
3.2 Global GLP-1-based Therapy Annual Revenue by Company (2021-2026)
3.2.1 Global GLP-1-based Therapy Revenue by Company (2021-2026)
3.2.2 Global GLP-1-based Therapy Revenue Market Share by Company (2021-2026)
3.3 Global GLP-1-based Therapy Sale Price by Company
3.4 Key Manufacturers GLP-1-based Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1-based Therapy Product Location Distribution
3.4.2 Players GLP-1-based Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1-BASED THERAPY BY GEOGRAPHIC REGION
4.1 World Historic GLP-1-based Therapy Market Size by Geographic Region (2021-2026)
4.1.1 Global GLP-1-based Therapy Annual Sales by Geographic Region (2021-2026)
4.1.2 Global GLP-1-based Therapy Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GLP-1-based Therapy Market Size by Country/Region (2021-2026)
4.2.1 Global GLP-1-based Therapy Annual Sales by Country/Region (2021-2026)
4.2.2 Global GLP-1-based Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas GLP-1-based Therapy Sales Growth
4.4 APAC GLP-1-based Therapy Sales Growth
4.5 Europe GLP-1-based Therapy Sales Growth
4.6 Middle East & Africa GLP-1-based Therapy Sales Growth
5 AMERICAS
5.1 Americas GLP-1-based Therapy Sales by Country
5.1.1 Americas GLP-1-based Therapy Sales by Country (2021-2026)
5.1.2 Americas GLP-1-based Therapy Revenue by Country (2021-2026)
5.2 Americas GLP-1-based Therapy Sales by Type (2021-2026)
5.3 Americas GLP-1-based Therapy Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1-based Therapy Sales by Region
6.1.1 APAC GLP-1-based Therapy Sales by Region (2021-2026)
6.1.2 APAC GLP-1-based Therapy Revenue by Region (2021-2026)
6.2 APAC GLP-1-based Therapy Sales by Type (2021-2026)
6.3 APAC GLP-1-based Therapy Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1-based Therapy by Country
7.1.1 Europe GLP-1-based Therapy Sales by Country (2021-2026)
7.1.2 Europe GLP-1-based Therapy Revenue by Country (2021-2026)
7.2 Europe GLP-1-based Therapy Sales by Type (2021-2026)
7.3 Europe GLP-1-based Therapy Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1-based Therapy by Country
8.1.1 Middle East & Africa GLP-1-based Therapy Sales by Country (2021-2026)
8.1.2 Middle East & Africa GLP-1-based Therapy Revenue by Country (2021-2026)
8.2 Middle East & Africa GLP-1-based Therapy Sales by Type (2021-2026)
8.3 Middle East & Africa GLP-1-based Therapy Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1-based Therapy
10.3 Manufacturing Process Analysis of GLP-1-based Therapy
10.4 Industry Chain Structure of GLP-1-based Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1-based Therapy Distributors
11.3 GLP-1-based Therapy Customer
12 WORLD FORECAST REVIEW FOR GLP-1-BASED THERAPY BY GEOGRAPHIC REGION
12.1 Global GLP-1-based Therapy Market Size Forecast by Region
12.1.1 Global GLP-1-based Therapy Forecast by Region (2027-2032)
12.1.2 Global GLP-1-based Therapy Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GLP-1-based Therapy Forecast by Type (2027-2032)
12.7 Global GLP-1-based Therapy Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1-based Therapy Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly GLP-1-based Therapy Product Portfolios and Specifications
13.2.3 Eli Lilly GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca GLP-1-based Therapy Product Portfolios and Specifications
13.3.3 AstraZeneca GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi GLP-1-based Therapy Product Portfolios and Specifications
13.4.3 Sanofi GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 GSK
13.5.1 GSK Company Information
13.5.2 GSK GLP-1-based Therapy Product Portfolios and Specifications
13.5.3 GSK GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 GSK Main Business Overview
13.5.5 GSK Latest Developments
13.6 Hanson
13.6.1 Hanson Company Information
13.6.2 Hanson GLP-1-based Therapy Product Portfolios and Specifications
13.6.3 Hanson GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hanson Main Business Overview
13.6.5 Hanson Latest Developments
13.7 Shanghai Renhui Biopharmaceutical
13.7.1 Shanghai Renhui Biopharmaceutical Company Information
13.7.2 Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Product Portfolios and Specifications
13.7.3 Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shanghai Renhui Biopharmaceutical Main Business Overview
13.7.5 Shanghai Renhui Biopharmaceutical Latest Developments
13.8 Huadong Medicine
13.8.1 Huadong Medicine Company Information
13.8.2 Huadong Medicine GLP-1-based Therapy Product Portfolios and Specifications
13.8.3 Huadong Medicine GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Huadong Medicine Main Business Overview
13.8.5 Huadong Medicine Latest Developments
13.9 Sino Biopharm
13.9.1 Sino Biopharm Company Information
13.9.2 Sino Biopharm GLP-1-based Therapy Product Portfolios and Specifications
13.9.3 Sino Biopharm GLP-1-based Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sino Biopharm Main Business Overview
13.9.5 Sino Biopharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GLP-1-based Therapy Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GLP-1-based Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Tablets
Table 5. Major Players of Other
Table 6. Global GLP-1-based Therapy Sales by Type (2021-2026) & (K Units)
Table 7. Global GLP-1-based Therapy Sales Market Share by Type (2021-2026)
Table 8. Global GLP-1-based Therapy Revenue by Type (2021-2026) & ($ million)
Table 9. Global GLP-1-based Therapy Revenue Market Share by Type (2021-2026)
Table 10. Global GLP-1-based Therapy Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global GLP-1-based Therapy Sale by Application (2021-2026) & (K Units)
Table 12. Global GLP-1-based Therapy Sale Market Share by Application (2021-2026)
Table 13. Global GLP-1-based Therapy Revenue by Application (2021-2026) & ($ million)
Table 14. Global GLP-1-based Therapy Revenue Market Share by Application (2021-2026)
Table 15. Global GLP-1-based Therapy Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global GLP-1-based Therapy Sales by Company (2021-2026) & (K Units)
Table 17. Global GLP-1-based Therapy Sales Market Share by Company (2021-2026)
Table 18. Global GLP-1-based Therapy Revenue by Company (2021-2026) & ($ millions)
Table 19. Global GLP-1-based Therapy Revenue Market Share by Company (2021-2026)
Table 20. Global GLP-1-based Therapy Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers GLP-1-based Therapy Producing Area Distribution and Sales Area
Table 22. Players GLP-1-based Therapy Products Offered
Table 23. GLP-1-based Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global GLP-1-based Therapy Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global GLP-1-based Therapy Sales Market Share Geographic Region (2021-2026)
Table 28. Global GLP-1-based Therapy Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global GLP-1-based Therapy Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global GLP-1-based Therapy Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global GLP-1-based Therapy Sales Market Share by Country/Region (2021-2026)
Table 32. Global GLP-1-based Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global GLP-1-based Therapy Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas GLP-1-based Therapy Sales by Country (2021-2026) & (K Units)
Table 35. Americas GLP-1-based Therapy Sales Market Share by Country (2021-2026)
Table 36. Americas GLP-1-based Therapy Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas GLP-1-based Therapy Sales by Type (2021-2026) & (K Units)
Table 38. Americas GLP-1-based Therapy Sales by Application (2021-2026) & (K Units)
Table 39. APAC GLP-1-based Therapy Sales by Region (2021-2026) & (K Units)
Table 40. APAC GLP-1-based Therapy Sales Market Share by Region (2021-2026)
Table 41. APAC GLP-1-based Therapy Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC GLP-1-based Therapy Sales by Type (2021-2026) & (K Units)
Table 43. APAC GLP-1-based Therapy Sales by Application (2021-2026) & (K Units)
Table 44. Europe GLP-1-based Therapy Sales by Country (2021-2026) & (K Units)
Table 45. Europe GLP-1-based Therapy Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe GLP-1-based Therapy Sales by Type (2021-2026) & (K Units)
Table 47. Europe GLP-1-based Therapy Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa GLP-1-based Therapy Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa GLP-1-based Therapy Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa GLP-1-based Therapy Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa GLP-1-based Therapy Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of GLP-1-based Therapy
Table 53. Key Market Challenges & Risks of GLP-1-based Therapy
Table 54. Key Industry Trends of GLP-1-based Therapy
Table 55. GLP-1-based Therapy Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. GLP-1-based Therapy Distributors List
Table 58. GLP-1-based Therapy Customer List
Table 59. Global GLP-1-based Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global GLP-1-based Therapy Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas GLP-1-based Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas GLP-1-based Therapy Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC GLP-1-based Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC GLP-1-based Therapy Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe GLP-1-based Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe GLP-1-based Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa GLP-1-based Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa GLP-1-based Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global GLP-1-based Therapy Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global GLP-1-based Therapy Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global GLP-1-based Therapy Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global GLP-1-based Therapy Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Novo Nordisk Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 74. Novo Nordisk GLP-1-based Therapy Product Portfolios and Specifications
Table 75. Novo Nordisk GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Novo Nordisk Main Business
Table 77. Novo Nordisk Latest Developments
Table 78. Eli Lilly Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 79. Eli Lilly GLP-1-based Therapy Product Portfolios and Specifications
Table 80. Eli Lilly GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Eli Lilly Main Business
Table 82. Eli Lilly Latest Developments
Table 83. AstraZeneca Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 84. AstraZeneca GLP-1-based Therapy Product Portfolios and Specifications
Table 85. AstraZeneca GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Latest Developments
Table 88. Sanofi Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi GLP-1-based Therapy Product Portfolios and Specifications
Table 90. Sanofi GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. GSK Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK GLP-1-based Therapy Product Portfolios and Specifications
Table 95. GSK GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. Hanson Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 99. Hanson GLP-1-based Therapy Product Portfolios and Specifications
Table 100. Hanson GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Hanson Main Business
Table 102. Hanson Latest Developments
Table 103. Shanghai Renhui Biopharmaceutical Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 104. Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Product Portfolios and Specifications
Table 105. Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Shanghai Renhui Biopharmaceutical Main Business
Table 107. Shanghai Renhui Biopharmaceutical Latest Developments
Table 108. Huadong Medicine Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 109. Huadong Medicine GLP-1-based Therapy Product Portfolios and Specifications
Table 110. Huadong Medicine GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Huadong Medicine Main Business
Table 112. Huadong Medicine Latest Developments
Table 113. Sino Biopharm Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 114. Sino Biopharm GLP-1-based Therapy Product Portfolios and Specifications
Table 115. Sino Biopharm GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Sino Biopharm Main Business
Table 117. Sino Biopharm Latest Developments
Table 1. GLP-1-based Therapy Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GLP-1-based Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Tablets
Table 5. Major Players of Other
Table 6. Global GLP-1-based Therapy Sales by Type (2021-2026) & (K Units)
Table 7. Global GLP-1-based Therapy Sales Market Share by Type (2021-2026)
Table 8. Global GLP-1-based Therapy Revenue by Type (2021-2026) & ($ million)
Table 9. Global GLP-1-based Therapy Revenue Market Share by Type (2021-2026)
Table 10. Global GLP-1-based Therapy Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global GLP-1-based Therapy Sale by Application (2021-2026) & (K Units)
Table 12. Global GLP-1-based Therapy Sale Market Share by Application (2021-2026)
Table 13. Global GLP-1-based Therapy Revenue by Application (2021-2026) & ($ million)
Table 14. Global GLP-1-based Therapy Revenue Market Share by Application (2021-2026)
Table 15. Global GLP-1-based Therapy Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global GLP-1-based Therapy Sales by Company (2021-2026) & (K Units)
Table 17. Global GLP-1-based Therapy Sales Market Share by Company (2021-2026)
Table 18. Global GLP-1-based Therapy Revenue by Company (2021-2026) & ($ millions)
Table 19. Global GLP-1-based Therapy Revenue Market Share by Company (2021-2026)
Table 20. Global GLP-1-based Therapy Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers GLP-1-based Therapy Producing Area Distribution and Sales Area
Table 22. Players GLP-1-based Therapy Products Offered
Table 23. GLP-1-based Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global GLP-1-based Therapy Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global GLP-1-based Therapy Sales Market Share Geographic Region (2021-2026)
Table 28. Global GLP-1-based Therapy Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global GLP-1-based Therapy Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global GLP-1-based Therapy Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global GLP-1-based Therapy Sales Market Share by Country/Region (2021-2026)
Table 32. Global GLP-1-based Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global GLP-1-based Therapy Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas GLP-1-based Therapy Sales by Country (2021-2026) & (K Units)
Table 35. Americas GLP-1-based Therapy Sales Market Share by Country (2021-2026)
Table 36. Americas GLP-1-based Therapy Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas GLP-1-based Therapy Sales by Type (2021-2026) & (K Units)
Table 38. Americas GLP-1-based Therapy Sales by Application (2021-2026) & (K Units)
Table 39. APAC GLP-1-based Therapy Sales by Region (2021-2026) & (K Units)
Table 40. APAC GLP-1-based Therapy Sales Market Share by Region (2021-2026)
Table 41. APAC GLP-1-based Therapy Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC GLP-1-based Therapy Sales by Type (2021-2026) & (K Units)
Table 43. APAC GLP-1-based Therapy Sales by Application (2021-2026) & (K Units)
Table 44. Europe GLP-1-based Therapy Sales by Country (2021-2026) & (K Units)
Table 45. Europe GLP-1-based Therapy Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe GLP-1-based Therapy Sales by Type (2021-2026) & (K Units)
Table 47. Europe GLP-1-based Therapy Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa GLP-1-based Therapy Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa GLP-1-based Therapy Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa GLP-1-based Therapy Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa GLP-1-based Therapy Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of GLP-1-based Therapy
Table 53. Key Market Challenges & Risks of GLP-1-based Therapy
Table 54. Key Industry Trends of GLP-1-based Therapy
Table 55. GLP-1-based Therapy Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. GLP-1-based Therapy Distributors List
Table 58. GLP-1-based Therapy Customer List
Table 59. Global GLP-1-based Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global GLP-1-based Therapy Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas GLP-1-based Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas GLP-1-based Therapy Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC GLP-1-based Therapy Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC GLP-1-based Therapy Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe GLP-1-based Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe GLP-1-based Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa GLP-1-based Therapy Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa GLP-1-based Therapy Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global GLP-1-based Therapy Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global GLP-1-based Therapy Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global GLP-1-based Therapy Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global GLP-1-based Therapy Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Novo Nordisk Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 74. Novo Nordisk GLP-1-based Therapy Product Portfolios and Specifications
Table 75. Novo Nordisk GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Novo Nordisk Main Business
Table 77. Novo Nordisk Latest Developments
Table 78. Eli Lilly Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 79. Eli Lilly GLP-1-based Therapy Product Portfolios and Specifications
Table 80. Eli Lilly GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Eli Lilly Main Business
Table 82. Eli Lilly Latest Developments
Table 83. AstraZeneca Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 84. AstraZeneca GLP-1-based Therapy Product Portfolios and Specifications
Table 85. AstraZeneca GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Latest Developments
Table 88. Sanofi Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi GLP-1-based Therapy Product Portfolios and Specifications
Table 90. Sanofi GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. GSK Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK GLP-1-based Therapy Product Portfolios and Specifications
Table 95. GSK GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. Hanson Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 99. Hanson GLP-1-based Therapy Product Portfolios and Specifications
Table 100. Hanson GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Hanson Main Business
Table 102. Hanson Latest Developments
Table 103. Shanghai Renhui Biopharmaceutical Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 104. Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Product Portfolios and Specifications
Table 105. Shanghai Renhui Biopharmaceutical GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Shanghai Renhui Biopharmaceutical Main Business
Table 107. Shanghai Renhui Biopharmaceutical Latest Developments
Table 108. Huadong Medicine Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 109. Huadong Medicine GLP-1-based Therapy Product Portfolios and Specifications
Table 110. Huadong Medicine GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Huadong Medicine Main Business
Table 112. Huadong Medicine Latest Developments
Table 113. Sino Biopharm Basic Information, GLP-1-based Therapy Manufacturing Base, Sales Area and Its Competitors
Table 114. Sino Biopharm GLP-1-based Therapy Product Portfolios and Specifications
Table 115. Sino Biopharm GLP-1-based Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Sino Biopharm Main Business
Table 117. Sino Biopharm Latest Developments
LIST OF FIGURES
Figure 1. Picture of GLP-1-based Therapy
Figure 2. GLP-1-based Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1-based Therapy Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global GLP-1-based Therapy Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GLP-1-based Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GLP-1-based Therapy Sales Market Share by Country/Region (2025)
Figure 10. GLP-1-based Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Tablets
Figure 13. Product Picture of Other
Figure 14. Global GLP-1-based Therapy Sales Market Share by Type in 2026
Figure 15. Global GLP-1-based Therapy Revenue Market Share by Type (2021-2026)
Figure 16. GLP-1-based Therapy Consumed in Type 2 Diabetes
Figure 17. Global GLP-1-based Therapy Market: Type 2 Diabetes (2021-2026) & (K Units)
Figure 18. GLP-1-based Therapy Consumed in Obesity
Figure 19. Global GLP-1-based Therapy Market: Obesity (2021-2026) & (K Units)
Figure 20. Global GLP-1-based Therapy Sale Market Share by Application (2025)
Figure 21. Global GLP-1-based Therapy Revenue Market Share by Application in 2026
Figure 22. GLP-1-based Therapy Sales by Company in 2026 (K Units)
Figure 23. Global GLP-1-based Therapy Sales Market Share by Company in 2026
Figure 24. GLP-1-based Therapy Revenue by Company in 2026 ($ millions)
Figure 25. Global GLP-1-based Therapy Revenue Market Share by Company in 2026
Figure 26. Global GLP-1-based Therapy Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global GLP-1-based Therapy Revenue Market Share by Geographic Region in 2026
Figure 28. Americas GLP-1-based Therapy Sales 2021-2026 (K Units)
Figure 29. Americas GLP-1-based Therapy Revenue 2021-2026 ($ millions)
Figure 30. APAC GLP-1-based Therapy Sales 2021-2026 (K Units)
Figure 31. APAC GLP-1-based Therapy Revenue 2021-2026 ($ millions)
Figure 32. Europe GLP-1-based Therapy Sales 2021-2026 (K Units)
Figure 33. Europe GLP-1-based Therapy Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa GLP-1-based Therapy Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa GLP-1-based Therapy Revenue 2021-2026 ($ millions)
Figure 36. Americas GLP-1-based Therapy Sales Market Share by Country in 2026
Figure 37. Americas GLP-1-based Therapy Revenue Market Share by Country (2021-2026)
Figure 38. Americas GLP-1-based Therapy Sales Market Share by Type (2021-2026)
Figure 39. Americas GLP-1-based Therapy Sales Market Share by Application (2021-2026)
Figure 40. United States GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC GLP-1-based Therapy Sales Market Share by Region in 2026
Figure 45. APAC GLP-1-based Therapy Revenue Market Share by Region (2021-2026)
Figure 46. APAC GLP-1-based Therapy Sales Market Share by Type (2021-2026)
Figure 47. APAC GLP-1-based Therapy Sales Market Share by Application (2021-2026)
Figure 48. China GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 52. India GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe GLP-1-based Therapy Sales Market Share by Country in 2026
Figure 56. Europe GLP-1-based Therapy Revenue Market Share by Country (2021-2026)
Figure 57. Europe GLP-1-based Therapy Sales Market Share by Type (2021-2026)
Figure 58. Europe GLP-1-based Therapy Sales Market Share by Application (2021-2026)
Figure 59. Germany GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 60. France GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 61. UK GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa GLP-1-based Therapy Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa GLP-1-based Therapy Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa GLP-1-based Therapy Sales Market Share by Application (2021-2026)
Figure 67. Egypt GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of GLP-1-based Therapy in 2026
Figure 73. Manufacturing Process Analysis of GLP-1-based Therapy
Figure 74. Industry Chain Structure of GLP-1-based Therapy
Figure 75. Channels of Distribution
Figure 76. Global GLP-1-based Therapy Sales Market Forecast by Region (2027-2032)
Figure 77. Global GLP-1-based Therapy Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global GLP-1-based Therapy Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global GLP-1-based Therapy Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global GLP-1-based Therapy Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global GLP-1-based Therapy Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of GLP-1-based Therapy
Figure 2. GLP-1-based Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1-based Therapy Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global GLP-1-based Therapy Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GLP-1-based Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GLP-1-based Therapy Sales Market Share by Country/Region (2025)
Figure 10. GLP-1-based Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Tablets
Figure 13. Product Picture of Other
Figure 14. Global GLP-1-based Therapy Sales Market Share by Type in 2026
Figure 15. Global GLP-1-based Therapy Revenue Market Share by Type (2021-2026)
Figure 16. GLP-1-based Therapy Consumed in Type 2 Diabetes
Figure 17. Global GLP-1-based Therapy Market: Type 2 Diabetes (2021-2026) & (K Units)
Figure 18. GLP-1-based Therapy Consumed in Obesity
Figure 19. Global GLP-1-based Therapy Market: Obesity (2021-2026) & (K Units)
Figure 20. Global GLP-1-based Therapy Sale Market Share by Application (2025)
Figure 21. Global GLP-1-based Therapy Revenue Market Share by Application in 2026
Figure 22. GLP-1-based Therapy Sales by Company in 2026 (K Units)
Figure 23. Global GLP-1-based Therapy Sales Market Share by Company in 2026
Figure 24. GLP-1-based Therapy Revenue by Company in 2026 ($ millions)
Figure 25. Global GLP-1-based Therapy Revenue Market Share by Company in 2026
Figure 26. Global GLP-1-based Therapy Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global GLP-1-based Therapy Revenue Market Share by Geographic Region in 2026
Figure 28. Americas GLP-1-based Therapy Sales 2021-2026 (K Units)
Figure 29. Americas GLP-1-based Therapy Revenue 2021-2026 ($ millions)
Figure 30. APAC GLP-1-based Therapy Sales 2021-2026 (K Units)
Figure 31. APAC GLP-1-based Therapy Revenue 2021-2026 ($ millions)
Figure 32. Europe GLP-1-based Therapy Sales 2021-2026 (K Units)
Figure 33. Europe GLP-1-based Therapy Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa GLP-1-based Therapy Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa GLP-1-based Therapy Revenue 2021-2026 ($ millions)
Figure 36. Americas GLP-1-based Therapy Sales Market Share by Country in 2026
Figure 37. Americas GLP-1-based Therapy Revenue Market Share by Country (2021-2026)
Figure 38. Americas GLP-1-based Therapy Sales Market Share by Type (2021-2026)
Figure 39. Americas GLP-1-based Therapy Sales Market Share by Application (2021-2026)
Figure 40. United States GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC GLP-1-based Therapy Sales Market Share by Region in 2026
Figure 45. APAC GLP-1-based Therapy Revenue Market Share by Region (2021-2026)
Figure 46. APAC GLP-1-based Therapy Sales Market Share by Type (2021-2026)
Figure 47. APAC GLP-1-based Therapy Sales Market Share by Application (2021-2026)
Figure 48. China GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 52. India GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe GLP-1-based Therapy Sales Market Share by Country in 2026
Figure 56. Europe GLP-1-based Therapy Revenue Market Share by Country (2021-2026)
Figure 57. Europe GLP-1-based Therapy Sales Market Share by Type (2021-2026)
Figure 58. Europe GLP-1-based Therapy Sales Market Share by Application (2021-2026)
Figure 59. Germany GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 60. France GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 61. UK GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa GLP-1-based Therapy Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa GLP-1-based Therapy Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa GLP-1-based Therapy Sales Market Share by Application (2021-2026)
Figure 67. Egypt GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries GLP-1-based Therapy Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of GLP-1-based Therapy in 2026
Figure 73. Manufacturing Process Analysis of GLP-1-based Therapy
Figure 74. Industry Chain Structure of GLP-1-based Therapy
Figure 75. Channels of Distribution
Figure 76. Global GLP-1-based Therapy Sales Market Forecast by Region (2027-2032)
Figure 77. Global GLP-1-based Therapy Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global GLP-1-based Therapy Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global GLP-1-based Therapy Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global GLP-1-based Therapy Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global GLP-1-based Therapy Revenue Market Share Forecast by Application (2027-2032)
